Key result
Beta-adrenoceptor blockade produced the greatest QTc interval shortening in adult males, with male LQTS1 patients showing a marked decrease in QTc dispersion and 100% treatment efficacy.
Why the study?
Does beta-adrenoceptor blockade affect QTc intervals and dispersion differently based on gender and genotype in patients with congenital long QT syndrome?
Observational (n=87)
Does beta-adrenoceptor blockade affect QTc intervals and dispersion differently based on gender and genotype in patients with congenital long QT syndrome?
Cardiac electrophysiological responses to beta-blockers in long QT syndrome are modulated by gender and genotype, with adult males showing the greatest QTc shortening.
BACKGROUND: Gender differences have been reported in patients with the congenital long QT syndrome (LQTS). We analyzed whether electrocardiographic differences existed in females, males, girls and boys in response to beta-adrenoceptor blockade. METHODS: 12-lead ECGs before and during beta-adrenoceptor blockade were collected in 87 genotyped LQTS patients (48 women, 14 men, 12 girls and 13 boys). Up to three QTc intervals were determined in each lead of the ECG. V4 was used for QT/QTc analysis. Difference between longest and shortest QT interval was taken as a measure for dispersion of QT intervals. RESULTS: (1) Adult males had the greatest shortening of the QTc interval upon treatment with beta-adrenoceptor blockade. During treatment, adult males with LQTS(1) (mutation in the KCNQ1 gene, affecting I(Ks) current) were found to have shorter QTc intervals than adult females; this difference did not exist in LQTS(2) patients (mutation in the HERG gene, affecting I(Kr) current). (2) Female LQTS(2) patients had a 50% larger dispersion than female LQTS(1) patients both before and during treatment. (3) Adult male LQTS(1) patients constitute the only patient group with a marked decrease in QTc intervals and dispersion associated with a 100% efficacy of treatment in response to beta-adrenoceptor blockade. CONCLUSIONS: These findings indicate that, in addition to underlying differences in repolarization between men and women, cardiac electrophysiological responses to beta-adrenoceptor blockade can be modulated by gender-related factors.
No takes yet. Share an insight, caveat, or question.
Chantal E. Conrath (2002) conducted an observational in congenital long QT syndrome (LQTS) (n=87). beta-adrenoceptor blockade vs. Before beta-adrenoceptor blockade (baseline) was evaluated on QTc interval and dispersion of QT intervals. Beta-adrenoceptor blockade produced the greatest QTc interval shortening in adult males, with male LQTS1 patients showing a marked decrease in QTc dispersion and 100% treatment efficacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: